Abstract
The molecular biology of aging has always been of extreme interest to researchers. Recent advances made through studies of model systems have greatly increased efforts to elucidate the mechanisms involved in aging. It now appears that in yeast there are two pathways controlling aging: i) the generation of extrachromosomal rDNA circles (ERCs) through the antagonistic action of Sir2p and Fob1p; and ii) the stress response pathway, regulated by the Sch9p and Tor1p kinases. The stress response pathway in higher eukaryotes is inhibited by the insulin-signaling pathway. Mutation to the AKT kinase disrupts insulin signaling and increases longevity. Yeast express orthologues of the insulin-signaling pathway, yet insulin is not a natural substrate for yeast. The yeast Sch9p is structurally and functionally related to the AKT kinase, but the remainder of the putative yeast AKT pathways is uncharacterized. Further mystery revolves around downstream targets that are directly required for longevity. Yeast provide an opportunity to investigate the function of the yeast AKT pathway at a molecular level. A potential downstream target has been identified in yeast that links the glucose and stress response pathways with lifespan: the Anaphase Promoting Complex (APC). This review will discuss the role the APC plays in established aging pathways in yeast and the implications on higher eukaryotes.
Keywords: Anaphase Promoting Complex, stress response pathway, caloric restriction, evolutionary conservation
Current Genomics
Title: The Anaphase Promoting Complex and Aging: The APCs of Longevity
Volume: 7 Issue: 4
Author(s): Troy A. A. Harkness
Affiliation:
Keywords: Anaphase Promoting Complex, stress response pathway, caloric restriction, evolutionary conservation
Abstract: The molecular biology of aging has always been of extreme interest to researchers. Recent advances made through studies of model systems have greatly increased efforts to elucidate the mechanisms involved in aging. It now appears that in yeast there are two pathways controlling aging: i) the generation of extrachromosomal rDNA circles (ERCs) through the antagonistic action of Sir2p and Fob1p; and ii) the stress response pathway, regulated by the Sch9p and Tor1p kinases. The stress response pathway in higher eukaryotes is inhibited by the insulin-signaling pathway. Mutation to the AKT kinase disrupts insulin signaling and increases longevity. Yeast express orthologues of the insulin-signaling pathway, yet insulin is not a natural substrate for yeast. The yeast Sch9p is structurally and functionally related to the AKT kinase, but the remainder of the putative yeast AKT pathways is uncharacterized. Further mystery revolves around downstream targets that are directly required for longevity. Yeast provide an opportunity to investigate the function of the yeast AKT pathway at a molecular level. A potential downstream target has been identified in yeast that links the glucose and stress response pathways with lifespan: the Anaphase Promoting Complex (APC). This review will discuss the role the APC plays in established aging pathways in yeast and the implications on higher eukaryotes.
Export Options
About this article
Cite this article as:
A. Harkness A. Troy, The Anaphase Promoting Complex and Aging: The APCs of Longevity, Current Genomics 2006; 7 (4) . https://dx.doi.org/10.2174/138920206778426997
DOI https://dx.doi.org/10.2174/138920206778426997 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
G Protein-Coupled Receptors in Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets The Spleen Tyrosine Kinase (Syk) in Human Disease, Implications for Design of Tyrosine Kinase Inhibitor Based Therapy
Current Pharmaceutical Design Anti-Cancer Therapy: Targeting the Mevalonate Pathway
Current Cancer Drug Targets Substance-Related Disorders and Somatic Symptoms: How Should Clinicians Understand the Associations?
Current Drug Abuse Reviews Angiotensin (1-7) and other Angiotensin Peptides
Current Pharmaceutical Design Current Status and Future Prospects of C1 Domain Ligands as Drug Candidates
Current Topics in Medicinal Chemistry New Anti-Angiogenic Targeted Therapy in Advanced Renal Cell Carcinoma (RCC):Current Status and Future Prospects
Reviews on Recent Clinical Trials Dietary Intervention for Allergic Disease
Current Pharmaceutical Design Cardiovascular Pharmacogenetics of Antihypertensive and Lipid- Lowering Therapies
Current Molecular Medicine Experimental Research on Nitric Oxide and the Therapy of Alzheimer Disease: A Challenging Bridge
CNS & Neurological Disorders - Drug Targets Impulse Control Disorders in Parkinson’s Disease: A Review
Current Psychiatry Reviews Modified Polysaccharides as Versatile Materials in Controlled Delivery of Antidegenerative Agents
Current Pharmaceutical Design The Role of Exhaled Nitric Oxide in the Diagnosis, Management and Treatment of Asthma
Mini-Reviews in Medicinal Chemistry Local Renin-Angiotensin II Systems, Angiotensin-Converting Enzyme and its Homologue ACE2: Their Potential Role in the Pathogenesis of Chronic Obstructive Pulmonary Diseases, Pulmonary Hypertension and Acute Respiratory Distress Syndrome
Current Medicinal Chemistry Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
Current Pharmaceutical Biotechnology Dietary Supplement Therapies for Inflammatory Bowel Disease: Crohn’s Disease and Ulcerative Colitis
Current Pharmaceutical Design The Acquired Deficiency of C1-Inhibitor: Lymphoproliferation and Angioedema
Current Molecular Medicine Putative Mechanisms of Action and Clinical Use of Lithium in Children and Adolescents: A Critical Review
Current Neuropharmacology Progress in Development of Group A Streptococcus Vaccines
Current Pharmaceutical Biotechnology Caregiver Involvement in Sexual Risk Reduction with Substance Using Juvenile Delinquents: Overview and Preliminary Outcomes of a Randomized Trial
Adolescent Psychiatry